AbCellera Biologics, Inc. ABCL 深 滬
已收盤 09-20 16:00:00 美东时间
2.59
-0.150
-5.47%
華盛通- 最 高2.73
- 今 開2.73
- 成交量 324.77万股
- 最 低 2.50
- 昨 收 2.74
- 總市值 7.59亿
- 52周最高 6.055
- 市盈率 靜 --
- 換手率 1.11%
- 52周最低 2.335
- 委 比 -88.85%
- 總股本 2.93亿
- 歷史最高 71.91
- 量 比 1.56
- 振 幅 8.39%
- 歷史最低 2.335
- 每 手 1
- 風險率 0.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-20 21:45
Understanding the Buy Rating: A Synopsis of AbCellera Biologics’ Investment Potential
Analyst David Martin PhD of Bloom Burton maintained a Buy rating on AbCellera B...
08-08 21:51
Exscientia(EXAI.US)获英伟达投资的Recursion(RXRX.US)收购 股价大涨16%
人工智能驱动的药物研发公司Recursion Pharmaceuticals(RXRX.US)已同意以6.88亿美元的价格全股票交易收购规模较小的竞争对手Exscientia(EXAI.US)
08-08 21:38
Nvidia-backed Recursion to acquire Exscientia in all-stock deal
Exscientia (NASDAQ:EXAI), an AI-driven drug discovery firm, has agreed to be acquired by its larger peer, Recursion Pharmaceuticals (NASDAQ:RXRX), whose backers include chipmaker Nvidia (NASDAQ:NVDA),...
08-08 19:54
Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
05-10 13:52
AbCellera Biologics Reviews Q1 Earnings with Corporate Presentation
An update from AbCellera Biologics (ABCL) is now available. On May 7, 2024, dur...
05-08 04:33
AbCellera partners with PE firms to develop antibody drugs, company creation
AbCellera (NASDAQ:ABCL) has inked an agreement with Viking Global Investors and ArrowMark Partners to develop new antibody drug programs, with an initial focus on immunology. The partnership also sees...
05-01 23:44
EU delays decision on Eisai-Biogen Alzheimer’s drug
The European Union's drug regulator has delayed it decision on Eisai (OTCPK:ESALF) (OTCPK:ESAIY) and partner Biogen's (NASDAQ:BIIB) breakthrough Alzheimer's therapy, Leqembi (lecanemab). Lecanemab, a ...
03-22 20:50
AbCellera To Collaborate With Biogen To Discover Therapeutic Antibodies For Neurological Conditions
AbCellera (NASDAQ:ABCL) and Biogen Inc. (NASDAQ:BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in
03-11 21:03
减肥药持续“热辣滚烫”之际 高盛大胆预测：未来几年还能将美国GDP提高1%!
分析师Jan Hatzius和他的团队认为，肥胖者不太可能工作，工作效率也较低。因此，假设美国的肥胖率超过40%，他们对国家总产出的影响超过1%。
02-23 06:54
